Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis. Buitrago-Molina LE, Pietrek J, Noyan F, Schlue J, et al. J Autoimmun 2020;117:102591.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Buitrago-Molina LE, Pietrek J, Noyan F, Schlue J, et al. Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis. J Autoimmun 2020;117:102591.
PMID: 33387980